Company Filing History:
3 out of 870 
1 out of 5,081 
1 out of 1,743 
Years Active: 2016-2022
Title: Benoit Marteyn: Innovator in Peptidomimetics and Polypeptides
Introduction
Benoit Marteyn is a distinguished inventor based in Paris, France. He has made significant contributions to the field of biochemistry, particularly in the development of peptidomimetics and polypeptides. With a total of 3 patents, his work has implications for medical research and treatment.
Latest Patents
Marteyn's latest patents include innovative methods and compositions related to peptidomimetics. One notable invention involves a peptidomimetic that comprises a D amino-acid sequence with at least 75% identity to specific sequences. This peptidomimetic is designed to interact with various biological components, including neutrophils and mucus proteins. Additionally, he has developed a solid-phase synthesis method for these peptidomimetics, which can be utilized as medicaments or markers for inflammation. Another patent focuses on polypeptides targeting glycosylated MUC2 proteins, which are crucial for detecting diseases such as colorectal cancer and cystic fibrosis. These inventions highlight his commitment to advancing medical diagnostics and therapeutics.
Career Highlights
Throughout his career, Benoit Marteyn has worked with prestigious institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. His research has been pivotal in understanding the role of peptidomimetics in inflammation and disease detection. His innovative approaches have garnered attention in the scientific community, contributing to advancements in biochemistry and medicine.
Collaborations
Marteyn has collaborated with notable colleagues, including Yves-Marie Coic and Francoise Baleux. These partnerships have enriched his research and expanded the impact of his inventions in the scientific field.
Conclusion
Benoit Marteyn's contributions to the field of biochemistry through his patents and research are noteworthy. His work on peptidomimetics and polypeptides has the potential to revolutionize medical diagnostics and treatment options. His innovative spirit continues to inspire advancements in the scientific community.